Type of Article
In the Section
Abstract
Amyotrophic lateral sclerosis (ALS) — is the neurodegenerative disease, which is accompanied by death of central and peri pheral motoneurons, by the steady progressing and fatal outcome. The prevalence of ALS in the world is 2—5/100 thousands of people in a year, thus at the last time there were marked the tendencies to the growth of ALS in all age groups. At the present time it is well known that the key factor of the pathogenesis of neuron’s death at ALS is the apoptosis activation. The only medicinal preparation, which is linked with the depressing of freeing of the glutamate by blocking the voltage-independent natrium canals, is Rylutek, which prolongs the life time, on the average, for 3 months. Another perspective direction of the pathogenetic treating of ALS is the usage of the drugs with neurotrophic action. Cerebrolysin it the only nootropic preparation with the neurotrophic action. It possesses such neurotrophic factors as NGF, CNTF, GDNF, IGF-1 and IGF-2, BDNF. It is known that neuron’s death arises as a result of deprivation of the neurotrophic factors. According to this, the application of Cerebrolysin in high doses is grounded for the given disease that also promotes the stabilization of the pathological process during 2 months.
Pages
Year / Issue
References
The Scientific and Practical Journal of Medicine
ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»